Carregando...

Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy

Warfarin and antihyperlipidemics are commonly co-prescribed. Some antihyperlipidemics may inhibit warfarin deactivation via the hepatic cytochrome P450 system. Therefore, antihyperlipidemic discontinuation has been hypothesized to result in underanticoagulation, as warfarin metabolism is no longer i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Principais autores: Leonard, Charles E., Brensinger, Colleen M., Bilker, Warren B., Kimmel, Stephen E., Whitaker, Heather J., Hennessy, Sean
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740131/
https://ncbi.nlm.nih.gov/pubmed/29269848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-18318-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!